剂量优化用于减少瘤负担,使用具有药物耐药连续性的表型结构人口模型
Lifeng Han1, Osman N Yogurtcu2, Marisabel Rodriguez Messan2
1Department of Mathematics, Tulane University, 6823 St. Charles Avenue, New Orleans, LA 70115, USA.
了解癌症的耐药性是关键. 这项研究使用了健身景观和药理动力学建模,以找到卵巢癌的最佳olaparib剂量策略,可能降低耐药性并改善治疗结果.
科学领域:
- 在瘤学瘤学.
- 数学生物学 数学生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐药性是癌症治疗的一个主要挑战.
- 奥拉巴里布是用于卵巢癌的向治疗,但可能会产生耐药性.
- 了解抵抗机制对于优化治疗至关重要.
研究的目的:
- 使用健身景观模型调查癌症耐药性的演变.
- 将药理动力学 (PK) 建模与耐药性演变相结合,以确定最佳药物剂量.
- 确定长期减少瘤的策略,并克服对olaparib的耐药性.
主要方法:
- 采用了基于健身景观概念的表型结构化人口模型.
- 将模型与卵巢癌中的olaparib实验数据相匹配.
- 集成的药理动力学 (PK) 建模来模拟药物度随时间推移.
- 导出了一个数学公式来指导剂量策略.
主要成果:
- 这项研究阐明了药物管理如何影响癌细胞健康格局.
- 追踪了癌细胞群体中药物耐药性的演变.
- 确定最大限度地提高血药物度的变化可能会降低耐药性.
- 在低于标签剂量的药物剂量下发现了改善结果的潜力.
结论:
- 结合PK和耐药性进化建模,为癌症治疗设计提供了一种新的方法.
- 优化剂量策略,可能涉及更低的剂量与不同的度,可以提高治疗效率.
- 这种综合建模方法可能为改进的癌症药物治疗方案铺平道路.
- 需要进一步的研究来验证这些发现,并完善治疗方案.
更多相关视频
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
相关概念视频
Analysis of Population Pharmacokinetic Data
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
